Red Violet director receives 2,179 RSU grant

Red Violet, Inc. director Steven D. Rubin reported a stock-based compensation grant.

Rhea-AI Filing Summary

Red Violet, Inc. director Steven D. Rubin reported a stock-based compensation grant. On June 4, 2026, he received 2,179 restricted stock units (RSUs) that convert into common stock on a one-for-one basis and vest on the earlier of one year from grant or the 2027 annual stockholders’ meeting, subject to possible accelerated vesting.

After this award, Rubin directly holds 147,767 shares of common stock, including several prior RSU grants with vesting dates in 2026–2028 and 59,200 vested RSUs for which he has deferred share delivery until separation from the company, death, or disability.

Insider Trade Summary

Grant/Award: 2,179 shares

Grant/Award 1 txn

Insider Rubin Steven D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,179	$0.00	$0.00

Holdings After Transaction: Common Stock — 147,767 shares (Direct)

Footnotes (5)

1. F1. On June 4, 2026, the reporting person received a grant of 2,179 restricted stock units ("RSUs"), convertible into common stock of the issuer on a one-for-one basis, which vests on the earlier of one year from the date of grant or the 2027 annual meeting of stockholders, subject to accelerated vesting under certain conditions.
2. F2. Includes 3,600 RSUs originally granted on November 30, 2023, convertible into common stock of the issuer on a one-for-one basis, which vests on December 1, 2026, subject to accelerated vesting under certain conditions.
3. F3. Includes 5,333 RSUs originally granted on November 4, 2024, convertible into common stock of the issuer on a one-for-one basis, which vests in two equal installments on each of November 1, 2026 and November 1, 2027, subject to accelerated vesting under certain circumstances.
4. F4. Includes 59,200 vested RSUs in which the reporting person has elected to defer delivery until the reporting person's separation of service from the issuer or death or disability.
5. F5. Includes 4,450 RSUs originally granted on December 19, 2025, convertible into common stock of the issuer on a one-for-one basis, which vests in three equal installments on each of December 1, 2026, December 1, 2027, and December 1, 2028, subject to accelerated vesting under certain circumstances.

Key Figures

New RSU grant: 2,179 RSUs Grant price: $0.00 per share Holdings after grant: 147,767 shares +4 more

7 metrics

New RSU grant 2,179 RSUs Granted June 4, 2026; one-for-one into common stock

Grant price $0.00 per share RSU award, non-cash compensation

Holdings after grant 147,767 shares Common stock directly held after June 4, 2026 grant

RSUs from Nov 30, 2023 grant 3,600 RSUs Vest on December 1, 2026, subject to conditions

RSUs from Nov 4, 2024 grant 5,333 RSUs Vest in two equal installments in 2026 and 2027

Deferred vested RSUs 59,200 RSUs Delivery deferred until separation, death, or disability

RSUs from Dec 19, 2025 grant 4,450 RSUs Vest in three equal installments 2026–2028

Key Terms

restricted stock units ("RSUs"), accelerated vesting, annual meeting of stockholders, defer delivery, +1 more

5 terms

restricted stock units ("RSUs") financial

"received a grant of 2,179 restricted stock units ("RSUs"), convertible into common stock"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

accelerated vesting financial

"vests on the earlier of one year from the date of grant or the 2027 annual meeting, subject to accelerated vesting"

A contract feature that makes stock awards, options, or restricted shares become owned or exercisable earlier than the original schedule. It shortens or cancels the waiting period so recipients can sell, transfer, or exercise their equity sooner — think of a timed lock that is unlocked ahead of schedule. It matters to investors because it changes when shares enter the market, who controls them, and how much dilution or ownership concentration happens.

annual meeting of stockholders financial

"vests on the earlier of one year from the date of grant or the 2027 annual meeting of stockholders"

defer delivery financial

"vested RSUs in which the reporting person has elected to defer delivery until the reporting person's separation of service"

separation of service financial

"defer delivery until the reporting person's separation of service from the issuer or death or disability"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Red Violet (RDVT) director Steven D. Rubin report in this Form 4?

Steven D. Rubin reported receiving 2,179 restricted stock units (RSUs) in Red Violet, Inc. The RSUs convert one-for-one into common stock and represent stock-based compensation, not an open-market purchase or sale of shares.

When do Steven D. Rubin’s new 2,179 RSUs in Red Violet (RDVT) vest?

The 2,179 RSUs granted to Steven D. Rubin vest on the earlier of one year from the June 4, 2026 grant date or the 2027 annual meeting of stockholders, with potential accelerated vesting under certain conditions described in the grant terms.

How many Red Violet (RDVT) shares does Steven D. Rubin hold after this RSU grant?

Following the June 4, 2026 RSU grant, Steven D. Rubin directly holds 147,767 shares of Red Violet common stock. This total includes previously granted RSUs with future vesting schedules and a block of vested RSUs with deferred share delivery.

What other RSU grants to Steven D. Rubin are outstanding at Red Violet (RDVT)?

Outstanding RSUs include 3,600 units granted November 30, 2023, 5,333 granted November 4, 2024, and 4,450 granted December 19, 2025. These vest on specified dates in 2026, 2027, and 2028, subject to possible accelerated vesting provisions.

What is notable about Steven D. Rubin’s 59,200 vested RSUs in Red Violet (RDVT)?

Rubin holds 59,200 vested RSUs where he has elected to defer share delivery. The shares will be delivered upon his separation of service from Red Violet, or upon his death or disability, effectively postponing receipt of the underlying common stock.

Is Steven D. Rubin’s June 2026 Red Violet (RDVT) transaction an open-market trade?

No, the June 2026 transaction is a grant of 2,179 RSUs at a price of $0.00 per unit. It reflects stock-based compensation awarded by the company, rather than an open-market purchase or sale of Red Violet common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/05/2026 - 04:57 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rubin Steven D

(Last) (First) (Middle)

C/O RED VIOLET, INC.

2650 N. MILITARY TRAIL, SUITE 300

(Street)

BOCA RATON FLORIDA 33431

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Red Violet, Inc. [ RDVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/04/2026		A		2,179(1)	A	(1)	147,767(1)(2)(3)(4)(5)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On June 4, 2026, the reporting person received a grant of 2,179 restricted stock units ("RSUs"), convertible into common stock of the issuer on a one-for-one basis, which vests on the earlier of one year from the date of grant or the 2027 annual meeting of stockholders, subject to accelerated vesting under certain conditions.

2. Includes 3,600 RSUs originally granted on November 30, 2023, convertible into common stock of the issuer on a one-for-one basis, which vests on December 1, 2026, subject to accelerated vesting under certain conditions.

3. Includes 5,333 RSUs originally granted on November 4, 2024, convertible into common stock of the issuer on a one-for-one basis, which vests in two equal installments on each of November 1, 2026 and November 1, 2027, subject to accelerated vesting under certain circumstances.

4. Includes 59,200 vested RSUs in which the reporting person has elected to defer delivery until the reporting person's separation of service from the issuer or death or disability.

5. Includes 4,450 RSUs originally granted on December 19, 2025, convertible into common stock of the issuer on a one-for-one basis, which vests in three equal installments on each of December 1, 2026, December 1, 2027, and December 1, 2028, subject to accelerated vesting under certain circumstances.

	/s/ Steven D. Rubin	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)